Calopad

Switzerland - Sempach, Luzern

• 25/08/2023
• Seed
• $4,539,000

Chronic pain is a global problem that is only getting worse. According to statistics, the number of people suffering from chronic pain is increasing every year. This has a major impact on their quality of life, as they are often unable to do the things they love or even simple everyday tasks.

Calopad offers a unique and holistic solution for chronic pain sufferers. Our world-renowned deep heat technology provides constant 42-degree heat, which quickly and effectively relieves muscle pain, tension and cramps. With our accompanying Physio-App, patients can receive personalized real-time care from a digital, AI based physiotherapist, regardless of time or location.

The efficacy of Calopad has been clinically proven and certified. We have seen high demand for our product since its launch in 2021 and it was sold out quickly after the official market launch. In addition, our product has a 69% better carbon footprint than traditional chemical heating pads.

If you suffer from chronic pain, we encourage you to try Calopad and see for yourself how we can help you regain your quality of life.

Related People

Michael BreiterCo Founder

Switzerland - Neuenkirch, Lucerne

I am Michael Breiter, CEO of Calopad AG and Chairman of the Board at Calenso AG. I am a serial entrepreneur with experience in strategy, business development, sales, medical technology, SaaS, marketing and management. I love turning an initial idea into a helpful product that improves people's lives.

LinkedIn https://www.linkedin.com/in/michael-breiter/